# US 2010/0145626 A1 · Systems for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0145626 A1
- Document ID: US20100145626A1
- Status: Published application
- Kind: A1
- Application number: 12/605,628
- Filed: 2009-10-26
- Published: 2010-06-10
- Earliest claimed: 2001-03-02
- Inventors: David J. Ecker; Richard H. Griffey; Rangarajan Sampath; Steven A. Hofstadler; John McNeil; Stanley T. Crooke; Lawrence B. Blyn; Thomas A. Hall; Yun Jiang; James C. Hannis; Neill White; Vivek Samant; Mark W. Eshoo; Jared J. Drader
- Web page: https://patentgrep.com/patent/US20100145626A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6858: Allele-specific amplification
- C12Q 1/6872: involving mass spectrometry
- C12Q 1/6888: for detection or identification of organisms
- C12Q 1/689: for bacteria
- C12Q 2600/156: Polymorphic or mutational markers
- G01N 2333/28: from Vibrionaceae (F)
- G01N 2333/32: from Bacillus (G)
- G01N 2333/35: from Mycobacteriaceae (F)
- G01N 2333/36: from Actinomyces; from Streptomyces (G)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides methods for rapid forensic analysis of mitochondrial DNA and methods for characterizing heteroplasmy of mitochondrial DNA, which can be used to assess the progression of mitochondrial diseases.

## Claims

### Claim at position 1

1-28. (canceled)

### Claim 29

A system, comprising:
at least one mass spectrometer configured to determine molecular masses of two or more amplification products, and/or fragments thereof, of two or more segments of mitochondrial DNA from a forensic evidence sample;
at least one database comprising a plurality of known molecular masses from said two or more segments of mitochondrial DNA, and/or fragments thereof, from a plurality of subjects; and,
at least one computer configured to compare said molecular masses of said two or more amplification products, and/or fragments thereof, with said plurality of known molecular masses to reach a forensic conclusion.

### Claim 30 (depends on 29)

The system of claim 29, wherein said mass spectrometer is an electrospray ionization mass spectrometer.

### Claim 31 (depends on 29)

The system of claim 29, wherein said database is a Federal Bureau of Investigation mitochondrial DNA database.

### Claim 32 (depends on 29)

The system of claim 29, wherein said computer is configured to determine relative amounts of said two or more amplification products, and/or fragments thereof, from abundance of mass spectral peaks corresponding to said two or more amplification products, and/or fragments thereof.

### Claim 33 (depends on 29)

The system of claim 29, comprising at least one nucleic acid isolation robot configured to isolate nucleic acids from forensic evidence samples.

### Claim 34 (depends on 29)

The system of claim 29, wherein said subjects are non-human eukaryotic organisms, fungi, parasites, or protozoa.

### Claim 35 (depends on 29)

The system of claim 29, wherein said two or more segments of mitochondrial DNA comprise a portion of a hypervariable region (HVR) of said mitochondrial DNA.

### Claim 36 (depends on 29)

The system of claim 29, wherein said hypervariable region comprises at least one of HVR1 or HVR2.

### Claim 37 (depends on 29)

The system of claim 29, wherein said forensic conclusion comprises identification of a missing person, detection and identification of a known bioagent, detection and identification of an unknown bioagent, elimination of an individual as a crime suspect, identification of an individual as a crime suspect, identification of a location as a crime scene, identification of a location as an accident scene, identification of evidence useful in a court of law, identification of evidence useful in a criminal investigation, or identification of one or more biological samples from a crime scene.

### Claim 38 (depends on 29)

The system of claim 29, wherein said forensic conclusion comprises an identity of a subject, wherein said computer matches said molecular masses of said amplification products with two or more of said known molecular masses to reach said forensic conclusion.

### Claim 39 (depends on 38)

The system of claim 38, wherein said forensic conclusion is the identification of a criminal.

### Claim 40 (depends on 38)

The system of claim 38, wherein said forensic conclusion is the identification of a crime victim.

### Claim 41 (depends on 29)

The system of claim 29, comprising at least one autosampler operably connected to said computer, which computer is configured to control said autosampler.

### Claim 42 (depends on 41)

The system of claim 41, comprising at least one microtiter plate comprising said two or more amplification products, wherein said autosampler is configured to transfer said two or more amplification products to said mass spectrometer.

### Claim 43 (depends on 29)

The system of claim 29, wherein said subjects are animals.

### Claim 44 (depends on 43)

The system of claim 43, wherein said animals are humans.

### Claim 45

A system, comprising:
at least one mass spectrometer configured to determine molecular masses of two or more amplification products, and/or fragments thereof, of two or more segments of mitochondrial DNA from a forensic evidence sample;
at least one database comprising a plurality of known base compositions from said two or more segments of mitochondrial DNA, and/or fragments thereof, from a plurality of subjects; and,
at least one computer configured to calculate base compositions of said two or more amplification products, and/or fragments thereof, from said molecular masses and to compare said base compositions of said two or more amplification products, and/or fragments thereof, with said plurality of known base compositions to reach a forensic conclusion.

### Claim 46 (depends on 45)

The system of claim 45, wherein said mass spectrometer is an electrospray ionization mass spectrometer.

### Claim 47 (depends on 45)

The system of claim 45, wherein said database is a Federal Bureau of Investigation mitochondrial DNA database.

### Claim 48 (depends on 45)

The system of claim 45, wherein said computer is configured to determine relative amounts of said two or more amplification products, and/or fragments thereof, from abundance of mass spectral peaks corresponding to said two or more amplification products, and/or fragments thereof.

### Claim 49 (depends on 45)

The system of claim 45, comprising at least one nucleic acid isolation robot configured to isolate nucleic acids from forensic evidence samples.

### Claim 50 (depends on 45)

The system of claim 45, wherein said subjects are non-human eukaryotic organisms, fungi, parasites, or protozoa.

### Claim 51 (depends on 45)

The system of claim 45, wherein said two or more segments of mitochondrial DNA comprise a portion of a hypervariable region (HVR) of said mitochondrial DNA.

### Claim 52 (depends on 45)

The system of claim 45, wherein said hypervariable region comprises at least one of HVR1 or HVR2.

### Claim 53 (depends on 45)

The system of claim 45, wherein said forensic conclusion comprises identification of a missing person, detection and identification of a known bioagent, detection and identification of an unknown bioagent, elimination of an individual as a crime suspect, identification of an individual as a crime suspect, identification of a location as a crime scene, identification of a location as an accident scene, identification of evidence useful in a court of law, identification of evidence useful in a criminal investigation, or identification of one or more biological samples from a crime scene.

### Claim 54 (depends on 45)

The system of claim 45, wherein said forensic conclusion comprises an identity of a subject, wherein said computer matches said base compositions of said amplification products with two or more of said known base compositions to reach said forensic conclusion.

### Claim 55 (depends on 54)

The system of claim 54, wherein said forensic conclusion is the identification of a crime victim.

### Claim 56 (depends on 54)

The system of claim 54, wherein said forensic conclusion is the identification of a criminal.

### Claim 57 (depends on 45)

The system of claim 45, comprising at least one autosampler operably connected to said computer, which computer is configured to control said autosampler.

### Claim 58 (depends on 57)

The system of claim 57, comprising at least one microtiter plate comprising said two or more amplification products, wherein said autosampler is configured to transfer said two or more amplification products to said mass spectrometer.

### Claim 59 (depends on 45)

The system of claim 45, wherein said subjects are animals.

### Claim 60 (depends on 59)

The system of claim 59, wherein said animals are humans.

### Claim 61

A system, comprising:
at least one mass spectrometer configured to determine molecular masses of two or more amplification products of two or more segments of mitochondrial DNA from a subject; and,
at least one computer configured to determine base compositions of said two or more amplification products from said molecular masses and to characterize heteroplasmy of said two or more segments of mitochondrial DNA from said base compositions.

### Claim 62 (depends on 61)

The system of claim 61, wherein said mass spectrometer is an electrospray ionization mass spectrometer.

### Claim 63 (depends on 61)

The system of claim 61, wherein said computer is configured to characterize length heteroplasmy, nucleotide polymorphism heteroplasmy, or both length heteroplasmy and nucleotide polymorphism heteroplasmy.

### Claim 64 (depends on 61)

The system of claim 61, wherein said computer is configured to characterize a rate of naturally occurring mutations in mitochondrial DNA.

### Claim 65 (depends on 61)

The system of claim 61, comprising at least one nucleic acid isolation robot configured to isolate nucleic acids from forensic evidence samples.

### Claim 66 (depends on 61)

The system of claim 61, comprising at least one database comprising a plurality of base compositions from said two or more segments of mitochondrial DNA from a plurality of subjects with one or more mitochondrial diseases.

### Claim 67 (depends on 66)

The system of claim 66, wherein said computer is configured to compare said base compositions of said two or more amplification products with one or more base compositions of said database to correlate said heteroplasmy with an onset of said one or more mitochondrial diseases in said subject.

### Claim 68 (depends on 66)

The system of claim 66, wherein said one or more mitochondrial diseases are selected from the group consisting of: Alpers Disease, Barth syndrome, Beta-oxidation Defects, Carnitine-Acyl-Carnitine Deficiency, Carnitine Deficiency, Co-Enzyme Q10 Deficiency, Complex I Deficiency, Complex II Deficiency, Complex III Deficiency, Complex IV Deficiency, Complex V Deficiency, COX Deficiency, CPEO, CPT I Deficiency, CPT II Deficiency, Glutaric Aciduria Type II, KSS, Lactic Acidosis, LCAD, LCHAD, Leigh Disease or Syndrome, LHON, Lethal Infantile Cardiomyopathy, Luft Disease, MAD, MCA, MELAS, MERRF, Mitochondrial Cytopathy, Mitochondrial DNA Depletion, Mitochondrial Encephalopathy, Mitochondrial Myopathy, MNGIE, NARP, Pearson Syndrome, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase Deficiency, Respiratory Chain, SCAD, SCHAD, and VLCAD.

### Claim 69 (depends on 61)

The system of claim 61, comprising at least one autosampler operably connected to said computer, which computer is configured to control said autosampler.

### Claim 70 (depends on 69)

The system of claim 69, comprising at least one microtiter plate comprising said two or more amplification products, wherein said autosampler is configured to transfer said two or more amplification products to said mass spectrometer.
